The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
ADMA Biologics shares fell 29% on April 6 due to claims of 'channel stuffing'. On the same day, law firm Bleichmar Fonti & Auld LLP launched an investigation into potential federal securities law violations. Investors are urged to contact the law firm regarding a potential class action lawsuit.